ACA
MRK icon

Aspire Capital Advisors’s Merck MRK Stock Holding History

Aspire Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
1,693
+9
+0.5% +$1.05K 0.04% 124
2026
Q1 		$203K Buy
+1,684
New +$194K 0.05% 120
2024
Q4 		– Sell
-2,024
Closed -$230K – 89
2024
Q3 		$230K Buy
2,024
+98
+5% +$11.6K 0.07% 72
2024
Q2 		$238K Sell
1,926
-209
-10% -$26.9K 0.08% 66
2024
Q1 		$282K Sell
2,135
-25
-1% -$3.08K 0.09% 63
2023
Q4 		$235K Buy
2,160
+7
+0.3% +$727 0.1% 59
2023
Q3 		$222K Buy
2,153
+78
+4% +$8.41K 0.1% 61
2023
Q2 		$239K Buy
+2,075
New +$236K 0.12% 55
2023
Q1 		– Sell
-1,823
Closed -$202K – 56
2022
Q4 		$202K Buy
+1,823
New +$186K 0.12% 50

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aspire Capital Advisors's MRK Position: Q2 2026 in Review

Aspire Capital Advisors increased its Merck (MRK) stake by 0.53% in Q2 2026, buying an estimated $1.05K and bringing the position to 1,693 shares worth $218K. The position accounts for 0.04% of the portfolio, ranked #124.

Aspire Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 9 quarters since. The position peaked at $282K in Q1 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspire Capital Advisors held 1,693 shares of Merck worth $218K as of Q2 2026.
  • Aspire Capital Advisors bought 9 Merck shares in Q2 2026, an estimated $1.05K.
  • Merck made up 0.04% of Aspire Capital Advisors's portfolio in Q2 2026, its #124 holding.
  • Aspire Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 9 quarters since.
  • Aspire Capital Advisors's Merck position peaked at $282K in Q1 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspire Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.